The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2013

Filed:

Jun. 13, 2011
Applicants:

Jean E. F. Rivier, La Jolla, CA (US);

Judit Erchegyi, San Diego, CA (US);

Jean Claude Reubi, Berne, CH;

Helmut R. Maecke, Basel, CH;

Inventors:

Jean E. F. Rivier, La Jolla, CA (US);

Judit Erchegyi, San Diego, CA (US);

Jean Claude Reubi, Berne, CH;

Helmut R. Maecke, Basel, CH;

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/31 (2006.01); A61K 3/10 (2006.01); A61K 7/12 (2006.01);
U.S. Cl.
CPC ...
Abstract

SRIF peptide antagonists, which are selective for SSTR2 in contrast to the other cloned SRIF receptors and which bind with high affinity to the cloned human receptor SSTR2 but do not activate the receptor, have many useful functions. Because they do not bind with significant affinity to SSTR1, SSTR3, SSTR4 or SSTR5, their administration avoids potential undesirable side effects. By incorporating radioiodine or the like in these SSTR2-selective SRIF antagonists, a labeled compound useful in drug-screening methods is provided. Alternatively, for use in therapy, highly radioactive moieties can be N-terminally coupled, complexed or chelated thereto. Because they block the receptor function, they can be used therapeutically to block certain physiological effects which SSTR2 mediates.


Find Patent Forward Citations

Loading…